The certificate of analysis for GLP-3 Reta 20mg, lot ACE-2753055, issued by ILS Laboratories on Sep 3, 2026. Every result below is copied from the certificate as the laboratory reported it, and the document itself is further down this page.
Certificate of analysisLOT ACE-2753055
ProductGLP-3 Reta 20mg
Name on certificateRetatrutide
LotACE-2753055
LaboratoryILS Laboratories
AccreditationISO/IEC 17025
Certificate no.COA-2026-V4X4IZ
Test typeFull QC Panel
Sample receivedAug 27, 2026
AnalysedSep 3, 2026
AppearanceGood
HPLC purity99.90%
IdentityRetatrutide (HPLC)
Overall resultPass
Verify with ILS Laboratories
Opens this certificate on the laboratory’s own site, access code NMHA97QY.
View GLP-3 Reta → Every GLP-3 Reta COA →Results as reported
| Test | Method | Result | Specification | Status |
|---|---|---|---|---|
| Purity | HPLC | 99.90% | — | Pass |
| Net Peptide Content | — | 21.37mg | — | Reported |
| Identity | HPLC | Retatrutide | — | Pass |
| Fentanyl Screen | — | Not Detected | — | Pass |
| Heavy Metals | ICP-MS | Not Detected | — | Pass |
| Sterility | PCR | No Growth | — | Pass |
| Endotoxin | USP <85> | 0.101 EU/mL | — | Reported |
“Reported” means the certificate gives a value without a pass or fail against a limit.
The certificate
More certificates
- GLP-3 Reta COA: every lot
- GLP-3 Reta 10mg, lot ACE-4798089
- GLP-3 Reta 30mg, lot ACE-3310727
- Purity index: every lot by HPLC purity
- Lot number lookup and all certificates
Sold for laboratory research use only.
